Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group (. Upto 50% off on subscriptions, Pfizer- 1QFY21 Result Update- Margins expansion helps net earnings growth despite revenue decline, Pfizer- 4QFY20 Result Update- COVID pandemic impacts performance, Ashika - Stock Picks - Pfizer Ltd. - May 2020, Pfizer- 3QFY20 Result Update- Lower tax outgo aids net profit outperformance, Pfizer- 4QFY19 Result Update- Higher Other Expenses dilute margins, Pfizer- ACCUMULATE- 3QFY19 Result Update- Robust Performance, Pfizer- Initiating Coverage- New Launches Critical To Drive Next Phase Of Growth. Zacks Investment Research, Tip: Try a valid symbol or a specific company name for relevant results, Singapore markets open in 2 hours 44 minutes, The Zacks Research Daily presents the best research output of our analyst team. On YoY basis, revenues were up 12.5%. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. - Sell->Hold). for Pfizer Ltd. have an average target of 4960.67. NSE: PFIZER Other noteworthy reports we are featuring today include SAP SE (, 3 Shares That Will Benefit When Phase III Kicks In, Airbus vs Boeing: legal battle of the titans, Why women are stereotyped as being terrible with money, Corporación América Airports S.A. Reports September 2020 Passenger Traffic, How He Made $2.8M Trading Stocks Part-Time At Home, Jacinda Ardern eyes historic election win in COVID-free New Zealand, Stock market news live updates: Stocks fall for a second day amid dimming stimulus prospects, mixed earnings, Shannonville Resident One Step Closer to Collecting Lottery Prize, Ikea to buy back used furniture in recycling push, Media advisory - Ministers Bains and O'Regan to announce investment in zero-emission energy technology, National Institutes of Health Launches its ACTIV-5 "Big Effect Trial" Evaluating Humanigen’s Lenzilumab™ as Potential COVID-19 Therapy, auの最新スマホは全機種5Gへ！XperiaやGalaxy、AQUOSなど各モデルの特徴を解説, Astex and Otsuka Announce Results of Phase 3 ASTRAL-2 and ASTRAL-3 Studies of Guadecitabine (SGI-110) in Patients with Previously Treated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia (MDS/CMML), Jobless claims preview: Another 825,000 Americans likely filed new unemployment claims last week, S&P Global Inc. (SPGI) : Free Stock Analysis Report, SAP SE (SAP) : Free Stock Analysis Report, Pfizer Inc. (PFE) : Free Stock Analysis Report, Novo Nordisk A/S (NVO) : Free Stock Analysis Report, Duke Energy Corporation (DUK) : Free Stock Analysis Report, Alibaba Group Holding Limited (BABA) : Free Stock Analysis Report. BSE Code: Pfizer's 17 brands are in No.1 position in the... FY18 revenues declined 3% YoY to | 1980 crore mainly due to GST impact, discontinuance of Corex cough syrup and divesture of certain brands.
Plot No 17-24 , Near Image Hospital, The Zacks Research Daily presents the best research output of our analyst team. Kenny Francis Oct 07, 2020 10:52AM ET. Since Pfizer does not have a chronic portfolio, the impact is likely to be steeper.
Their average twelve-month price target is $39.44, predicting that the stock has a possible upside of 8.42%. Pfizer, Alopexx Pharmaceuticals, LLC, Novartis AG, GlaxoSmithKline plc, Abbott, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Bayer AG, Johnson & Johnson Services Sanofi and Cipla LUPIN among others. Per the Zacks Analyst, its rising premiums on expanded product offerings and strength in retirement business have led to top-line growth. Report », More from Auditor's However, elevated expenses continue to weigh on margins. EBITDA declined 2.2% on QoQ basis and grew 9.0% on YoY basis. However, long-term debt of more than C$34.2 billion is a concern. The... Trending news The 6 reports from 3 analysts offering long term price targets (You can read the full research report on Alibaba here >>>). Per the Zacks analyst, steady investments in infrastructure and expansion projects are expected to boost Duke Energy's earnings growth. Monday, April 13, 2020. Please use S&P 500 as compatible index for RS analysis. IST, Updated:14 Oct, 2020, 16:01 PM Per the Zacks analyst, Hi-Crush should gain from acquisitions and continuous expansion actions. We Vishal Manchanda... produce millions of vaccines by end2020. All rights reserved. NSE Symbol:
Coronavirus Woes and High Competition to Ail Penske (PAG). In a report issued on August 31, Barclays also maintained a Buy rating on the stock with a $32.00 price target. EBITDA outperformance was driven by a superior gross margin. On the flip side, the looming... stood at Rs 20,815mn, up 5.1%. This is aiding growth in Tmall Import, Hema fresh food grocery business and Intime Department Stores. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. PFE updated stock price target summary. In a report released today, Randall Stanicky from RBC Capital maintained a Buy rating on Pfizer, with a price target of $43.00.
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group (BABA), Pfizer …